Who invested in Rapid Pathogen Screening?
Rapid Pathogen Screening's investors include OrbiMed.
United States · Funded startup
4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Rapid Pathogen Screening and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$56Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.3M sold, first sale Oct 2012
No investor was named in the report.
Reported by sec.govSEC filing: $6.8M sold, first sale Sept 2010
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Jan 2009
Rapid Pathogen Screening filed 4 raises, $30M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 3 on the team.
On the board, as filediCaroline T. PopperCharles T. SaldariniDaniel SamburskyJules MusingerStephen R. La NeveThomas Orsini
Rapid Pathogen Screening's investors include OrbiMed.
Rapid Pathogen Screening has raised $56M across 4 rounds since 2010.
Rapid Pathogen Screening's most recent round was a Debt of $28M in Oct 2014.
Its most recent round, $28M in Oct 2014, is also its largest on record.
Rapid Pathogen Screening's first round on record, in Oct 2014, was backed by OrbiMed.
Rapid Pathogen Screening's latest named round is a Debt, in Oct 2014.
Rapid Pathogen Screening is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.